// App-Quantinova.ai

789.0 : ECOG performance status as a predictor of adjuvant chemotherapy (AC) toxicities in stage III colorectal cancer (CRC) patients.

Researchers

Presenter

  • Akie Watanabe

Principal Investigators

  • Charlie Yang

  • Winson Y. Cheung

Medical Centers

  • The University of British Columbia, Vancouver, BC, Canada

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Capecitabine

  • Oxaliplatin, 5-fluorouracil and folic acid

  • Capecitabine + Oxaliplatin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved